Kimberly A Vnuk-kronick, CRNA | |
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
(734) 936-4000 | |
Not Available |
Full Name | Kimberly A Vnuk-kronick |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 31 Years |
Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437162138 | NPI | - | NPPES |
3400820 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 4707165414 (Michigan) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.
The battle for the future of Medicaid in Virginia is expected to heat up, with both sides of the divide playing close attention to a proposal to expand the program through the state budget.
MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
A simple blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson's disease or another atypical parkinsonism disorder, according to a new study published in the February 8, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Regents Of The University Of Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528010428 PECOS PAC ID: 3779496856 Enrollment ID: O20031121000336 |
News Archive
MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.
The battle for the future of Medicaid in Virginia is expected to heat up, with both sides of the divide playing close attention to a proposal to expand the program through the state budget.
MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
A simple blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson's disease or another atypical parkinsonism disorder, according to a new study published in the February 8, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kimberly A Vnuk-kronick, CRNA 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Kimberly A Vnuk-kronick, CRNA 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.
The battle for the future of Medicaid in Virginia is expected to heat up, with both sides of the divide playing close attention to a proposal to expand the program through the state budget.
MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
A simple blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson's disease or another atypical parkinsonism disorder, according to a new study published in the February 8, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Denise Lynn Berry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Ashley Marie Dibardino, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Terrance Solan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Paula K Globerson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Lawrence R Stump, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Mary Catherine Downey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Renee Ann Shea, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |